Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmine Ferrara

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Empirical Software Engineering|November 29, 2023
Fairness-aware machine learning engineering: how far are we?Carmine Ferrara, Giulia Sellitto, Filomena Ferrucci, et al.
Critical Reviews in Oncology/Hematology|June 23, 2004
The role of targeted therapy in non-small cell lung cancerPaolo Maione, Antonio Rossi, Giuseppe Airoma, et al.
Tumori|May 7, 2002
Chemotherapy of advanced NSCLC in the elderlyCesare Gridelli, Carmine Ferrara, Filomena Del Gaizo, et al.
The Oncologist|June 22, 2005
Treatment of small cell lung cancer in the elderlyAntonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Critical Reviews in Oncology/Hematology|June 28, 2005
Screening for lung cancer: New horizons?Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Expert Opinion on Pharmacotherapy|October 13, 2007
Erlotinib in non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Targeted Oncology|January 18, 2013
ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLCFrancesca Casaluce, Assunta Sgambato, Paolo Maione, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Oral cytotoxic drugsCesare Gridelli, Antonio Rossi, Ciro Guerriero, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancerCesare Gridelli, Paolo Maione, Domenico Galetta, et al.
Current Drug Discovery Technologies|June 13, 2009
Recent developments of targeted therapies in the treatment of non-small cell lung cancerAntonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Empirical Software Engineering|November 29, 2023
Fairness-aware machine learning engineering: how far are we?Carmine Ferrara, Giulia Sellitto, Filomena Ferrucci, et al.
Critical Reviews in Oncology/Hematology|June 23, 2004
The role of targeted therapy in non-small cell lung cancerPaolo Maione, Antonio Rossi, Giuseppe Airoma, et al.
Tumori|May 7, 2002
Chemotherapy of advanced NSCLC in the elderlyCesare Gridelli, Carmine Ferrara, Filomena Del Gaizo, et al.
The Oncologist|June 22, 2005
Treatment of small cell lung cancer in the elderlyAntonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Critical Reviews in Oncology/Hematology|June 28, 2005
Screening for lung cancer: New horizons?Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Expert Opinion on Pharmacotherapy|October 13, 2007
Erlotinib in non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Targeted Oncology|January 18, 2013
ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLCFrancesca Casaluce, Assunta Sgambato, Paolo Maione, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Oral cytotoxic drugsCesare Gridelli, Antonio Rossi, Ciro Guerriero, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancerCesare Gridelli, Paolo Maione, Domenico Galetta, et al.
Current Drug Discovery Technologies|June 13, 2009
Recent developments of targeted therapies in the treatment of non-small cell lung cancerAntonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Pageof 2